Atlas Trials

A Study of Apatinib in Recurrent or Recurrent High-grade Glioma

Clinical trial NCT03390062 · UNKNOWN

Trial details

NCT number
NCT03390062
Sponsor
West China Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Glioma
Start date
2018-01-04
Primary completion
2019-12-20
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.